Stage IV Ovarian Cancer Completed Phase 1 Trials for Eribulin (DB08871)

IndicationStatusPhase
DBCOND0030167 (Stage IV Ovarian Cancer)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00410553Eribulin Mesylate and Gemcitabine Hydrochloride in Treating Patients With Metastatic Solid Tumors or Solid Tumors That Cannot be Removed by SurgeryTreatment